Because no large Caucasian series was tested for EGFR genetic heterogeneity, we addressed this question in clinical testing conditions thanks to a French nationwide EGFR mutation characterization program in advanced lung cancer (National Cancer Institute, INCa). The gene discussed is EGFR; the disease is lung cancer.